Feasibility and Safety of Neoadjuvant Alectinib in a Patient With ALK-Positive Locally Advanced NSCLC

Chao Zhang1, Li-Xu Yan2, Ben-Yuan Jiang1

  • 1Guangdong Lung Cancer Institute, Guangdong Provincial Key Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People's Hospital & Guangdong Academy of Medical Sciences, Guangzhou, People's Republic of China.

Abstract

No abstract available in PubMed .

Related Concept Videos